On September 15, CHINA LIFE fell 3.02% in regular trading, trading at HK$28.9/share, with turnover of HK$709 million. The broader insurance sector weakened in tandem, with China Taiping down 4.55%, NCI down 2.54%, and Ping An down 1.21%.

On the news front, the Ministry of Finance previously announced a 35 billion yuan capital injection into the China Life Insurance Group — the largest single tranche among the combined 70 billion yuan earmarked for five state-owned insurers. Notably, the injection targets the group entity rather than the listed subsidiary, and market sentiment has remained volatile as investors continue to assess its implications. Analysts have flagged that CHINA LIFE's first-half net profit of 134.49 billion yuan was heavily driven by equity market performance, with fair value gains contributing significantly. Should equity market volatility intensify in the second half, profit sustainability could face downward pressure.

Separately, CHINA LIFE's Benxi and Yili branches were recently penalized a combined 921,000 yuan by local regulators for violations including unauthorized policy terms, granting policyholders extra-contractual benefits, and fabricating intermediary business to extract fees.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)